Skip to main content

US ClosedU.S. Closed

JUNS: Jupiter Neurosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development.

52W Range

0thpctl

Volume

0.28×avg

Market Cap

2.03MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Jupiter Neurosciences, Inc.

JUNSNASDAQ Capital Market·USD·Closed

Jupiter Neurosciences, Inc.

JUNSNASDAQ·USD·Closed

$4.18

−14.52%

$4.18

−$0.71 (14.52%)

52W Range

0thpctl

Volume

0.28×avg

Mkt Cap

2.03MUSD

P/E

-0.4TTM

Div Yield

–ann